{
    "id": "934d892a-a1d7-4283-b78a-7f10da1ff34f",
    "indications": {
        "text": "carvedilol tablets alpha-/beta-adrenergic blocking agent indicated treatment : \u2022 mild severe chronic heart failure ( 1.1 ) \u2022 left ventricular dysfunction following myocardial infarction clinically stable patients ( 1.2 ) \u2022 hypertension ( 1.3 )",
        "doid_entities": [
            {
                "text": "myocardial infarction (DOID:5844)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_5844"
            },
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "carvedilol tablets taken food slow rate absorption reduce incidence orthostatic effects .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "carvedilol tablets , usp available following strengths : 3.125 mg \u2013 white , film-coated circular shaped tablets \u2018 g \u2019 engraved one side plain side overbagged 10 film-coated tablets per bag , ndc 55154-2641-0 6.25 mg \u2013 white , film-coated circular shaped tablets \u2018 g \u2019 engraved one side \u2018 41 \u2019 engraved side overbagged 10 film-coated tablets per bag , ndc 55154-2649-0 12.5 mg \u2013 white , film-coated capsule shaped tablets \u2018 g \u2019 engraved one side \u2018 164 \u2019 engraved side overbagged 10 film-coated tablets per bag , ndc 55154-2648-0 25 mg \u2013 white , film-coated circular shaped tablets \u2018 g41 \u2019 engraved one side \u2018 25 \u2019 engraved side overbagged 10 film-coated tablets per bag , ndc 55154-2640-0 store 20\u00b0c 25\u00b0c ( 68\u00b0f 77\u00b0f ) [ usp controlled room temperature ] . protect moisture . dispense tight container .",
    "adverseReactions": "carvedilol contraindicated following conditions : \u2022bronchial asthma related bronchospastic conditions . deaths status asthmaticus reported following single doses carvedilol . \u2022second third-degree av block . \u2022sick sinus syndrome . \u2022severe bradycardia ( unless permanent pacemaker place ) . \u2022patients cardiogenic shock decompensated heart failure requiring intravenous inotropic therapy . patients first weaned intravenous therapy initiating carvedilol . \u2022patients severe hepatic impairment . \u2022patients history serious hypersensitivity reaction ( e.g . , stevens-johnson syndrome , anaphylactic reaction , angioedema ) component medication medications containing carvedilol .",
    "ingredients": [
        {
            "name": "CARVEDILOL",
            "code": "0K47UL67F2",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_3441"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "CROSPOVIDONE (120 .MU.M)",
            "code": "68401960MK"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "LACTOSE, UNSPECIFIED FORM",
            "code": "J2B2A4N98G",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "POLYSORBATE 80",
            "code": "6OZP39ZG8H",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_53426"
        },
        {
            "name": "POVIDONE, UNSPECIFIED",
            "code": "FZ989GH94E"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        }
    ],
    "organization": "Cardinal Health 107, LLC",
    "name": "Carvedilol",
    "effectiveTime": "20250519",
    "indications_original": "Carvedilol tablets are an alpha-/beta-adrenergic blocking agent indicated for the treatment of: \u2022 mild to severe chronic heart failure ( 1.1 ) \u2022 left ventricular dysfunction following myocardial infarction in clinically stable patients ( 1.2 ) \u2022 hypertension ( 1.3 )",
    "contraindications_original": "Carvedilol tablets should be taken with food to slow the rate of absorption and reduce the incidence of orthostatic effects.",
    "warningsAndPrecautions_original": "Carvedilol Tablets, USP are available in the following strengths: \n                  3.125 mg \u2013 White, film-coated circular shaped tablets with \u2018G\u2019 engraved on one side and plain on the other side\n                  Overbagged with 10 film-coated tablets per bag,\u00a0NDC 55154-2641-0\n                  6.25 mg \u2013 White, film-coated circular shaped tablets with \u2018G\u2019 engraved on one side and \u201841\u2019 engraved on the other side\n                  Overbagged with 10 film-coated tablets per bag,\u00a0NDC 55154-2649-0\n                  12.5 mg \u2013 White, film-coated capsule shaped tablets with \u2018G\u2019 engraved on one side and \u2018164\u2019 engraved on the other side\n                  Overbagged with 10 film-coated tablets per bag,\u00a0NDC 55154-2648-0\n                  25 mg \u2013 White, film-coated circular shaped tablets with \u2018G41\u2019 engraved on one side and \u201825\u2019 engraved on the other side\n                  Overbagged with 10 film-coated tablets per bag,\u00a0NDC 55154-2640-0\n                  Store at 20\u00b0C to 25\u00b0C (68\u00b0F to 77\u00b0F) [see USP Controlled Room Temperature]. Protect from moisture. Dispense in a tight container.",
    "adverseReactions_original": "Carvedilol is contraindicated in the following conditions:\n                  \n                     \n                        \u2022Bronchial asthma or related bronchospastic conditions. Deaths from status asthmaticus have been reported following single doses of carvedilol.\n                     \n                        \u2022Second or third-degree AV block.\n                     \n                        \u2022Sick sinus syndrome.\n                     \n                        \u2022Severe bradycardia (unless a permanent pacemaker is in place).\n                     \n                        \u2022Patients with cardiogenic shock or who have decompensated heart failure requiring the use of intravenous inotropic therapy. Such patients should first be weaned from intravenous therapy before initiating carvedilol.\n                     \n                        \u2022Patients with severe hepatic impairment.\n                     \n                        \u2022Patients with a history of a serious hypersensitivity reaction (e.g., Stevens-Johnson syndrome, anaphylactic reaction, angioedema) to any component of this medication or other medications containing carvedilol.",
    "drug": [
        {
            "name": "Carvedilol",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_3441"
        }
    ]
}